{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T16:16:38Z","timestamp":1774887398019,"version":"3.50.1"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T00:00:00Z","timestamp":1774828800000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute of Drug Abuse","doi-asserted-by":"crossref","award":["R21DA058815"],"award-info":[{"award-number":["R21DA058815"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000026","name":"National Institute of Drug Abuse","doi-asserted-by":"crossref","award":["R21DA058815"],"award-info":[{"award-number":["R21DA058815"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000026","name":"National Institute of Drug Abuse","doi-asserted-by":"crossref","award":["R21DA058815"],"award-info":[{"award-number":["R21DA058815"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000026","name":"National Institute of Drug Abuse","doi-asserted-by":"crossref","award":["R21DA058815"],"award-info":[{"award-number":["R21DA058815"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000026","name":"National Institute of Drug Abuse","doi-asserted-by":"crossref","award":["R21DA058815"],"award-info":[{"award-number":["R21DA058815"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000026","name":"National Institute of Drug Abuse","doi-asserted-by":"crossref","award":["R21DA058815"],"award-info":[{"award-number":["R21DA058815"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"DOI":"10.1186\/s12884-026-08711-3","type":"journal-article","created":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T04:54:13Z","timestamp":1771908853000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["An intervention mapping approach to closing the gap in maternal OUD and infant NOWS care: a study protocol"],"prefix":"10.1186","volume":"26","author":[{"given":"Sara L.","family":"Kornfield","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma","family":"Farber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erica M.","family":"Reisinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nia","family":"Bhadra-Heintz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Navid","family":"Roder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca F.","family":"Hamm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry","family":"Kranzler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David S.","family":"Mandell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Becker-Haimes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,24]]},"reference":[{"issue":"31","key":"8711_CR1","doi-asserted-by":"publisher","first-page":"845","DOI":"10.15585\/mmwr.mm6731a1","volume":"10","author":"SC Haight","year":"2018","unstructured":"Haight SC, Ko JY, Tong VT, Bohm MK, Callaghan WM. Opioid use disorder documented at delivery Hospitalization - United States, 1999\u20132014. MMWR Morb Mortal Wkly Rep Aug. 2018;10(31):845\u20139. https:\/\/doi.org\/10.15585\/mmwr.mm6731a1.","journal-title":"MMWR Morb Mortal Wkly Rep Aug"},{"issue":"2","key":"8711_CR2","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1089\/jwh.2020.8875","volume":"30","author":"J Campbell","year":"2021","unstructured":"Campbell J, Matoff-Stepp S, Velez ML, Cox HH, Laughon K. Pregnancy-Associated deaths from Homicide, Suicide, and drug overdose: review of research and the intersection with intimate partner violence. J Womens Health (Larchmt) Feb. 2021;30(2):236\u201344. https:\/\/doi.org\/10.1089\/jwh.2020.8875.","journal-title":"J Womens Health (Larchmt) Feb"},{"issue":"9","key":"8711_CR3","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1001\/jamapsychiatry.2017.2161","volume":"74","author":"BF Grant","year":"2017","unstructured":"Grant BF, Chou SP, Saha TD, et al. Prevalence of 12-month alcohol use, high-risk drinking, and DSM-IV alcohol use disorder in the united States, 2001\u20132002 to 2012\u20132013: results from the National epidemiologic survey on alcohol and related conditions. JAMA Psychiatry. 2017;74(9):911\u201323.","journal-title":"JAMA Psychiatry"},{"issue":"21","key":"8711_CR4","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1001\/jama.2022.17045","volume":"328","author":"E Bruzelius","year":"2022","unstructured":"Bruzelius E, Martins SS. US trends in drug overdose mortality among pregnant and postpartum persons, 2017\u20132020. JAMA. 2022;328(21):2159\u201361.","journal-title":"JAMA"},{"key":"8711_CR5","doi-asserted-by":"publisher","unstructured":"Shankaran S, Lester BM, Das A, et al. Impact of maternal substance use during pregnancy on childhood outcome. Semin Fetal Neonatal Med. Apr 2007;12(2):143\u201350. https:\/\/doi.org\/10.1016\/j.siny.2007.01.002.","DOI":"10.1016\/j.siny.2007.01.002"},{"key":"8711_CR6","unstructured":"Abuse S. Results from the 2010 National survey on drug use and health: summary of National findings. ERIC Clearinghouse; 2011."},{"issue":"4","key":"8711_CR7","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1111\/j.1552-6909.2000.tb02059.x","volume":"29","author":"JE Corrarino","year":"2000","unstructured":"Corrarino JE, Williams C, Campbell WS III, Amrhein E, Kalachik D, LoPiano L. Linking substance-abusing pregnant women to drug treatment services: a pilot program. J Obstetric Gynecologic Neonatal Nurs. 2000;29(4):369\u201376.","journal-title":"J Obstetric Gynecologic Neonatal Nurs"},{"issue":"5","key":"8711_CR8","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1097\/AOG.0000000000000208","volume":"123","author":"RJ Desai","year":"2014","unstructured":"Desai RJ, Hernandez-Diaz S, Bateman BT, Huybrechts KF. Increase in prescription opioid use during pregnancy among Medicaid-enrolled women. Obstet Gynecol May. 2014;123(5):997\u20131002. https:\/\/doi.org\/10.1097\/AOG.0000000000000208.","journal-title":"Obstet Gynecol May"},{"issue":"1","key":"8711_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40429-017-0132-4","volume":"4","author":"CL Arnaudo","year":"2017","unstructured":"Arnaudo CL, Andraka-Christou B, Allgood K. Psychiatric Co-Morbidities in pregnant women with opioid use disorders: Prevalence, Impact, and implications for treatment. Curr Addict Rep. 2017;4(1):1\u201313. https:\/\/doi.org\/10.1007\/s40429-017-0132-4.","journal-title":"Curr Addict Rep"},{"issue":"2","key":"8711_CR10","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.ejogrb.2010.02.026","volume":"150","author":"SM Pinto","year":"2010","unstructured":"Pinto SM, Dodd S, Walkinshaw SA, Siney C, Kakkar P, Mousa HA. Substance abuse during pregnancy: effect on pregnancy outcomes. Eur J Obstet Gynecol Reprod Biol Jun. 2010;150(2):137\u201341. https:\/\/doi.org\/10.1016\/j.ejogrb.2010.02.026.","journal-title":"Eur J Obstet Gynecol Reprod Biol Jun"},{"key":"8711_CR11","doi-asserted-by":"publisher","unstructured":"CampbellKA, Wilson AL, Torres M, Dantuluri N, Fryer K. Risk factors of overdose in maternal patients with opioid use disorder: a scoping review. Am J Drug Alcohol Abus. 2025:51(1):4\u201313 . https:\/\/doi.org\/10.1080\/00952990.2024.2407006","DOI":"10.1080\/00952990.2024.2407006"},{"issue":"2","key":"8711_CR12","doi-asserted-by":"publisher","first-page":"e81","DOI":"10.1097\/AOG.0000000000002235","volume":"130","author":"Obstetricians","year":"2017","unstructured":"Obstetricians, ACo. Gynecologists. Opioid use and opioid use disorder in pregnancy. Committee opinion 711. Obstet Gynecol. 2017;130(2):e81\u201394.","journal-title":"Obstet Gynecol"},{"issue":"5","key":"8711_CR13","doi-asserted-by":"publisher","first-page":"100419","DOI":"10.1016\/j.ajogmf.2021.100419","volume":"3","author":"E Patel","year":"2021","unstructured":"Patel E, Bandara S, Saloner B, et al. Heterogeneity in prenatal substance use screening despite universal screening recommendations: findings from the pregnancy risk assessment monitoring System, 2016\u20132018. Am J Obstet Gynecol MFM. 2021;3(5):100419.","journal-title":"Am J Obstet Gynecol MFM"},{"issue":"1","key":"8711_CR14","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1097\/ADM.0000000000000827","volume":"16","author":"KA Ahrens","year":"2022","unstructured":"Ahrens KA, McBride CA, O\u2019Connor A, Meyer MC. Medication for addiction treatment and postpartum health care utilization among pregnant persons with opioid use disorder. J Addict Med. 2022;16(1):56\u201364.","journal-title":"J Addict Med"},{"issue":"4","key":"8711_CR15","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.ajog.2021.04.210","volume":"225","author":"DM Schiff","year":"2021","unstructured":"Schiff DM, Nielsen TC, Hoeppner BB, et al. Methadone and buprenorphine discontinuation among postpartum women with opioid use disorder. Am J Obstet Gynecol. 2021;225(4):424. e1-424. e12.","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"8711_CR16","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1097\/AOG.0000000000002734","volume":"132","author":"DM Schiff","year":"2018","unstructured":"Schiff DM, Nielsen T, Terplan M, et al. Fatal and nonfatal overdose among pregnant and postpartum women in Massachusetts. Obstet Gynecol. 2018;132(2):466\u201374.","journal-title":"Obstet Gynecol"},{"key":"8711_CR17","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s10995-010-0594-7","volume":"15","author":"SC Roberts","year":"2011","unstructured":"Roberts SC, Pies C. Complex calculations: how drug use during pregnancy becomes a barrier to prenatal care. Matern Child Health J. 2011;15:333\u201341.","journal-title":"Matern Child Health J"},{"issue":"25","key":"8711_CR18","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.1056\/NEJMra1600879","volume":"375","author":"K McQueen","year":"2016","unstructured":"McQueen K, Murphy-Oikonen J. Neonatal abstinence syndrome. N Engl J Med. 2016;375(25):2468\u201379. https:\/\/doi.org\/10.1056\/NEJMra1600879.","journal-title":"N Engl J Med"},{"issue":"9","key":"8711_CR19","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1111\/add.13842","volume":"112","author":"TE Corr","year":"2017","unstructured":"Corr TE, Hollenbeak CS. The economic burden of neonatal abstinence syndrome in the united States. Addiction. 2017;112(9):1590\u20139.","journal-title":"Addiction"},{"issue":"31","key":"8711_CR20","doi-asserted-by":"publisher","first-page":"799","DOI":"10.15585\/mmwr.mm6531a2","volume":"65","author":"JY Ko","year":"2016","unstructured":"Ko JY, Patrick SW, Tong VT, Patel R, Lind JN, Barfield WD. Incidence of neonatal abstinence Syndrome \u2013 28 States, 1999\u20132013. MMWR Morb Mortal Wkly Rep. 2016;65(31):799\u2013802.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"3","key":"8711_CR21","doi-asserted-by":"publisher","first-page":"e20183801","DOI":"10.1542\/peds.2018-3801","volume":"143","author":"MA Honein","year":"2019","unstructured":"Honein MA, Boyle C, Redfield RR. Public health surveillance of prenatal opioid exposure in mothers and infants. Pediatrics. 2019;143(3):e20183801. https:\/\/doi.org\/10.1542\/peds.2018-3801.","journal-title":"Pediatrics"},{"issue":"2","key":"8711_CR22","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1001\/jama.2020.24991","volume":"325","author":"AH Hirai","year":"2021","unstructured":"Hirai AH, Ko JY, Owens PL, Stocks C, Patrick SW. Neonatal abstinence syndrome and maternal Opioid-Related diagnoses in the US, 2010\u20132017. JAMA. 2021;325(2):146\u201355. https:\/\/doi.org\/10.1001\/jama.2020.24991.","journal-title":"JAMA"},{"key":"8711_CR23","doi-asserted-by":"publisher","first-page":"e2017","DOI":"10.1542\/peds.2017-3520","volume":"141","author":"TNA Winkelman","year":"2018","unstructured":"Winkelman TNA, Villapiano N, Kozhimannil KB, Davis MM, Patrick SW. Incidence and costs of neonatal abstinence syndrome among infants with medicaid. Pediatrics. 2018;141:e2017\u20133520.","journal-title":"Pediatrics"},{"key":"8711_CR24","doi-asserted-by":"publisher","unstructured":"Patrick SW, Barfield WD, Poindexter BB. Neonatal opioid withdrawal syndrome. Pediatrics. 2020;146(5). https:\/\/doi.org\/10.1542\/peds.2020-029074.","DOI":"10.1542\/peds.2020-029074"},{"issue":"7","key":"8711_CR25","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1007\/s10995-023-03614-7","volume":"27","author":"J Frankeberger","year":"2023","unstructured":"Frankeberger J, Jarlenski M, Krans EE, Coulter RW, Mair C. Opioid use disorder and overdose in the first year postpartum: a rapid scoping review and implications for future research. Matern Child Health J. 2023;27(7):1140\u201355.","journal-title":"Matern Child Health J"},{"issue":"1","key":"8711_CR26","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.contraception.2018.08.008","volume":"99","author":"A Kotha","year":"2019","unstructured":"Kotha A, Chen BA, Lewis L, Dunn S, Himes KP, Krans EE. Prenatal intent and postpartum receipt of long-acting reversible contraception among women receiving medication-assisted treatment for opioid use disorder. Contraception. 2019;99(1):36\u201341.","journal-title":"Contraception"},{"issue":"18","key":"8711_CR27","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1001\/jama.2012.3951","volume":"307","author":"SW Patrick","year":"2012","unstructured":"Patrick SW, Schumacher RE, Benneyworth BD, Krans EE, McAllister JM, Davis MM. Neonatal abstinence syndrome and associated health care expenditures: united States, 2000\u20132009. JAMA. 2012;307(18):1934\u201340.","journal-title":"JAMA"},{"key":"8711_CR28","doi-asserted-by":"crossref","unstructured":"Tolia VN, Patrick SW, Bennett MM et al. Increasing incidence of the neonatal abstinence syndrome in U.S. neonatal ICUs. N Engl J Med. 2015;372(22):2118\u20132126pmid:25913111.","DOI":"10.1056\/NEJMsa1500439"},{"issue":"3","key":"8711_CR29","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/s41372-019-0535-2","volume":"40","author":"JY Ko","year":"2020","unstructured":"Ko JY, Tong VT, Haight SC, Terplan M, Snead C, Schulkin J. Obstetrician-gynecologists\u2019 practice patterns related to opioid use during pregnancy and postpartum-United States, 2017. J Perinatol. 2020;40(3):412\u201321. https:\/\/doi.org\/10.1038\/s41372-019-0535-2.","journal-title":"J Perinatol"},{"issue":"2","key":"8711_CR30","doi-asserted-by":"publisher","first-page":"104","DOI":"10.3122\/jabfm.18.2.104","volume":"18","author":"DA Seehusen","year":"2005","unstructured":"Seehusen DA, Baldwin LM, Runkle GP, Clark G. Are family physicians appropriately screening for postpartum depression? J Am Board Family Med. 2005;18(2):104\u201312. https:\/\/doi.org\/10.3122\/jabfm.18.2.104.","journal-title":"J Am Board Family Med"},{"issue":"9","key":"8711_CR31","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1089\/jwh.2016.6089","volume":"26","author":"SS Olin","year":"2017","unstructured":"Olin SS, McCord M, Stein REK, et al. Beyond screening: A stepped care pathway for managing postpartum depression in pediatric settings. J Womens Health (Larchmt). 2017;26(9):966\u201375. https:\/\/doi.org\/10.1089\/jwh.2016.6089.","journal-title":"J Womens Health (Larchmt)"},{"issue":"3","key":"8711_CR32","doi-asserted-by":"publisher","first-page":"e185","DOI":"10.1097\/ADM.0000000000000909","volume":"16","author":"S Choi","year":"2022","unstructured":"Choi S, Rosenbloom D, Stein MD, Raifman J, Clark JA. Differential gateways, facilitators, and barriers to substance use disorder treatment for pregnant women and mothers: a scoping systematic review. J Addict Med. 2022;16(3):e185\u201396.","journal-title":"J Addict Med"},{"key":"8711_CR33","unstructured":"Abuse S, Administration MHS. Clinical guidance for treating pregnant and parenting women with opioid use disorder and their infants. Substance Abuse and Mental Health Services Administration Rockville, MD; 2018."},{"issue":"5","key":"8711_CR34","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1097\/ADM.0000000000000166","volume":"9","author":"K Kampman","year":"2015","unstructured":"Kampman K, Jarvis M. American society of addiction medicine (ASAM) National practice guideline for the use of medications in the treatment of addiction involving opioid use. J Addict Med. 2015;9(5):358\u201367.","journal-title":"J Addict Med"},{"key":"8711_CR35","unstructured":"Kornfield S, Wolk C, Mandell D. Evaluating NICU provider attitudes about OUD referral and treatment for mothers of babies with NAS. 2024. [manuscript in preparation]. This manuscript is still in preparation and has not been published yet."},{"issue":"209","key":"8711_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fpubh.2019.00209","volume":"7","author":"ME Fernandez","year":"2019","unstructured":"Fernandez ME, Ruiter RAC, Markham CM, Kok G. Intervention mapping: Theory- and evidence-based health promotion program planning: perspective and examples. Front Public Health. 2019;7(209):1\u20138. https:\/\/doi.org\/10.3389\/fpubh.2019.00209.","journal-title":"Front Public Health"},{"key":"8711_CR37","doi-asserted-by":"crossref","unstructured":"Highfield L, Hartman MA, Dolan Mullen P, Rodriguez SA, Fernandez ME, Bartholomew LK. Intervention mapping to adapt evidence-based interventions for use in practice: increasing mammography among African American women. BioMed research international. 2015.","DOI":"10.1155\/2015\/160103"},{"key":"8711_CR38","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.2105\/AJPH.2012.301165","volume":"103","author":"RC Brownson","year":"2013","unstructured":"Brownson RC, Jacobs JA, Tabak RG, Hoehner CM, Stamatakis KA. Designing for dissemination among public health researchers: findings from a National survey in the united States. Am J Public Health. 2013;103:1693\u20139. https:\/\/doi.org\/10.2105\/AJPH.2012.301165.","journal-title":"Am J Public Health"},{"key":"8711_CR39","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/1748-5908-4-50","volume":"4","author":"LJ Damschroder","year":"2009","unstructured":"Damschroder LJ, Aron DC, Keith RE, Kirsh SR, Alexander JA, Lowery JC. Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implement Sci. 2009;4:50. https:\/\/doi.org\/10.1186\/1748-5908-4-50. PMID: 19664226; PMCID: PMC2736161.","journal-title":"Implement Sci"},{"key":"8711_CR40","doi-asserted-by":"publisher","unstructured":"Becker-Haimes EM, Mandell DS, Fishman J, et al. Assessing causal pathways and targets of implementation variability for EBP use (Project ACTIVE): a study protocol. Implement Sci Commun. 2021;2(1). https:\/\/doi.org\/10.1186\/s43058-021-00245-3.","DOI":"10.1186\/s43058-021-00245-3"},{"key":"8711_CR41","doi-asserted-by":"publisher","unstructured":"Fernandez ME, ten Hoor GA, van Lieshout S, et al. Implementation mapping: using intervention mapping to develop implementation strategies. Front Public Health. 2019;7(158). https:\/\/doi.org\/10.3389\/fpubh.2019.00158.","DOI":"10.3389\/fpubh.2019.00158"},{"issue":"1","key":"8711_CR42","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13012-019-0892-4","volume":"14","author":"TJ Waltz","year":"2019","unstructured":"Waltz TJ, Powell BJ, Fern\u00e1ndez ME, Abadie B, Damschroder LJ. Choosing implementation strategies to address contextual barriers: diversity in recommendations and future directions. Implement Sci. 2019;14(1):42. https:\/\/doi.org\/10.1186\/s13012-019-0892-4. PMID: 31036028; PMCID: PMC6489173.","journal-title":"Implement Sci"},{"key":"8711_CR43","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12911-019-0744-9","volume":"19","author":"S Potthoff","year":"2019","unstructured":"Potthoff S, Presseau J, Sniehotta FF, Breckons M, Rylance A, Avery L. Exploring the role of competing demands and routines during the implementation of a self-management tool for type 2 diabetes: A theory based qualitative interview study. BMC Med Inf Decis Mak. 2019;19:23.","journal-title":"BMC Med Inf Decis Mak"},{"issue":"1","key":"8711_CR44","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1177\/1525822X05279903","volume":"1","author":"G Guest","year":"2006","unstructured":"Guest G, Bunce A, Johnson L. How many interviews are enough? An experiment with data saturation and variability. Field Methods Febr. 2006;1(1):59\u201382.","journal-title":"Field Methods Febr"},{"key":"8711_CR45","first-page":"220","volume-title":"Handbook for qualitative research","author":"J Morse","year":"1994","unstructured":"Morse J. Designing funded qualitative research. In: Denzin N, Lincoln Y, editors. Handbook for qualitative research. Thousand Oaks, CA: Sage; 1994. pp. 220\u201335."},{"key":"8711_CR46","first-page":"31","volume-title":"Doing qualitative research","author":"AJ Kuzel","year":"1992","unstructured":"Kuzel AJ. Sampling in qualitative inquiry. In: Crabtree BF, Miller WL, editors. Doing qualitative research. Newbury Park, California: Sage; 1992. pp. 31\u201344."},{"key":"8711_CR47","unstructured":"Graves TD. Behavioral anthropology: toward an integrated science of human behavior. Walnut Creek, CA: Roman & Littlefield; 2004."},{"issue":"114523","key":"8711_CR48","first-page":"1","volume":"292","author":"M Hennink","year":"2022","unstructured":"Hennink M, Kaiser BN. Sample sizes for saturation in qualitative research: A systematic review of empirical tests. Soc Sci Med January. 2022;292(114523):1\u201310.","journal-title":"Soc Sci Med January"},{"key":"8711_CR49","volume-title":"Predicting and changing behavior: the reasoned action approach","author":"M Fishbein","year":"2010","unstructured":"Fishbein M, Ajzen I. Predicting and changing behavior: the reasoned action approach. New York: Psychology; 2010."},{"key":"8711_CR50","volume-title":"Dissemination and implementation of Evidence-Based practices in child and adolescent mental health","author":"N Williams","year":"2014","unstructured":"Williams N, Glisson C. The role of organizational culture and climate in the dissemination and implementation of empirically supported treatments for youth. In: Beidas R, Kendall P, editors. Dissemination and implementation of Evidence-Based practices in child and adolescent mental health. New York: Oxford; 2014."},{"issue":"6","key":"8711_CR51","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1080\/15374416.2014.910791","volume":"43","author":"LA Palinkas","year":"2014","unstructured":"Palinkas LA. Qualitative and mixed methods in mental health services and implementation research. J Clin Child Adolesc Psychol. 2014;43(6):851\u201361. https:\/\/doi.org\/10.1080\/15374416.2014.910791.","journal-title":"J Clin Child Adolesc Psychol"},{"issue":"1","key":"8711_CR52","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s13012-014-0157-1","volume":"9","author":"MG Ehrhart","year":"2014","unstructured":"Ehrhart MG, Aarons GA, Farahnak LR. Assessing the organizational context for EBP implementation:the development and validity testing of the implementation climate scale (ICS). Implement Sci. 2014;9(1):157.","journal-title":"Implement Sci"},{"issue":"4","key":"8711_CR53","doi-asserted-by":"publisher","first-page":"268","DOI":"10.7326\/M16-2149","volume":"166","author":"PT Korthuis","year":"2017","unstructured":"Korthuis PT, McCarty D, Weimer M, et al. Primary Care-Based models for the treatment of opioid use disorder: A scoping review. Ann Intern Med. 2017;166(4):268\u201378. https:\/\/doi.org\/10.7326\/M16-2149.","journal-title":"Ann Intern Med"},{"issue":"5","key":"8711_CR54","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1001\/archinternmed.2010.541","volume":"171","author":"DP Alford","year":"2011","unstructured":"Alford DP, LaBelle CT, Kretsch N, Bergeron A, Winter M, Botticelli M, et al. Collaborative care of opioid addicted patients in primary care using buprenorphine: five-year experience. Arch Intern Med. 2011;171(5):425\u201331.","journal-title":"Arch Intern Med"},{"key":"8711_CR55","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.jsat.2015.06.010","volume":"60","author":"CT LaBelle","year":"2016","unstructured":"LaBelle CT, Han SC, Bergeron A, Samet JH. Office-Based opioid treatment with buprenorphine (OBOTB): statewide implementation of the Massachusetts collaborative care model in community health centers. J Subst Abuse Treat. 2016;60:6\u201313.","journal-title":"J Subst Abuse Treat"},{"issue":"3","key":"8711_CR56","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1007\/s11904-018-0396-x","volume":"15","author":"KM Rich","year":"2018","unstructured":"Rich KM, Bia J, Altice FL, Feinberg J. Integrated models of care for individuals with opioid use disorder: how do we prevent HIV and HCV? Curr HIV\/AIDS Rep. 2018;15(3):266\u201375. https:\/\/doi.org\/10.1007\/s11904-018-0396-x.","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"5","key":"8711_CR57","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1086\/500200","volume":"42","author":"S Basu","year":"2006","unstructured":"Basu S, Smith-Rohrberg D, Bruce RD, Altice FL. Models for integrating buprenorphine therapy into the primary HIV care setting. Clin Infect Dis. 2006;42(5):716\u201321. https:\/\/doi.org\/10.1086\/500200. Epub 2006 Jan 24. PMID: 16447120.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"8711_CR58","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1186\/s13063-020-04278-2","volume":"21","author":"J Morrison","year":"2020","unstructured":"Morrison J, Hasselblad M, Kleinpell R, Buie R, Ariosto D, Hardiman E, Osborn SW, Lindsell CJ, Vanderbilt Learning Healthcare System Investigators, Vanderbilt University. The disruptive bEhavior management and prevention in hospitalized patients using a behavioral intervention team (DEMEANOR) study protocol: a pragmatic, cluster, crossover trial. Trials. 2020;21(1):417. https:\/\/doi.org\/10.1186\/s13063-020-04278-2. PMID: 32448331; PMCID: PMC7245750.","journal-title":"Trials"},{"issue":"3","key":"8711_CR59","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1053\/j.semperi.2019.01.002","volume":"43","author":"E Johnson","year":"2019","unstructured":"Johnson E. Models of care for opioid dependent pregnant women. Semin Perinatol. 2019;43(3):132\u201340. https:\/\/doi.org\/10.1053\/j.semperi.2019.01.002. Epub 2019 Jan 14. PMID: 30981471.","journal-title":"Semin Perinatol"},{"key":"8711_CR60","unstructured":"State of Vermont. Vermont Blueprint for Health. Blueprintforhealth.vermont.gov."},{"key":"8711_CR61","unstructured":"Newman SD, Andrews JO, Magwood GS, Jenkins C, Cox MJ, Williamson DC. Community advisory boards in community-based participatory research: A synthesis of best practices. Preventing Chronic Disease: Public Health Res Pract Policy. 2011;8(3):A70 ."},{"issue":"Suppl 3","key":"8711_CR62","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2106\/JBJS.H.01573","volume":"91","author":"B Kooistra","year":"2009","unstructured":"Kooistra B, Dijkman B, Einhorn TA, Bhandari M. How to design a good case series. J Bone Joint Surg Am. 2009;91(Suppl 3):21\u20136. https:\/\/doi.org\/10.2106\/JBJS.H.01573.","journal-title":"J Bone Joint Surg Am"},{"issue":"1","key":"8711_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2288-11-100","volume":"11","author":"S Crowe","year":"2011","unstructured":"Crowe S, Cresswell K, Robertson A, Huby G, Avery A, Sheikh A. The case study approach. BMC Med Res Methodol. 2011;11(1):1\u20139. https:\/\/doi.org\/10.1186\/1471-2288-11-100.","journal-title":"BMC Med Res Methodol"},{"key":"8711_CR64","doi-asserted-by":"publisher","unstructured":"Griffin D, Audige L. Common statistical methods in orthopaedic clinical studies. Clin Orthop Relat Res. 2003;41370\u20139. https:\/\/doi.org\/10.1097\/01.blo.0000080538.81794.1d.","DOI":"10.1097\/01.blo.0000080538.81794.1d"},{"issue":"4","key":"8711_CR65","first-page":"557","volume":"12","author":"FM Abu-Zidan","year":"2012","unstructured":"Abu-Zidan FM, Abbas AK, Hefny AF. Clinical case series: a concept analysis. Afr Health Sci. 2012;12(4):557\u201362.","journal-title":"Afr Health Sci"},{"key":"8711_CR66","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1177\/0962280215588241","volume":"25","author":"AL Whitehead","year":"2016","unstructured":"Whitehead AL, Julious SA, Cooper CL, Campbell MJ. Estimating the sample size for a pilot randomized trial to minimise the overall trial sample size for the external pilot and main trial for a continuous outcome variable. Stat Methods Med Res. 2016;25:1057\u201373. https:\/\/doi.org\/10.1177\/0962280215588241.","journal-title":"Stat Methods Med Res"},{"issue":"9","key":"8711_CR67","first-page":"1","volume":"2","author":"Philadelphia Department of Public H","year":"2017","unstructured":"Philadelphia Department of Public Health. Prescription opioid and benzodiazepine use in Philadelphia, 2017. CHART. 2017;2(9):1\u20136.","journal-title":"CHART"},{"key":"8711_CR68","unstructured":"Mehta A, Hoffman R, Tew S, Huynh MP. Improving outcomes: maternal mortality Philadelphia. City Phila; 2021:1\u201324. Accessed January 13, 2025. https:\/\/www.phila.gov\/media\/20210322093837\/MMRReport2020-FINAL.pdf"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-026-08711-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-026-08711-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-026-08711-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T15:33:14Z","timestamp":1774884794000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12884-026-08711-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,24]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8711"],"URL":"https:\/\/doi.org\/10.1186\/s12884-026-08711-3","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,24]]},"assertion":[{"value":"2 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board of the University of Pennsylvania Perelman School of Medicine.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"HK is a member of advisory boards for Altimmune and Clearmind Medicine; a consultant to Sobrera Pharmaceuticals and Altimmune; the recipient of research funding and medication supplies for an investigator-initiated study from Alkermes; a member of the American Society of Clinical Psychopharmacology\u2019s Alcohol Clinical Trials Initiative, which was supported in the last three years by Alkermes, Dicerna, Ethypharm, Imbrium, Indivior, Kinnov, Lilly, Otsuka, and Pear; and an inventor on U.S. provisional patent 63\/710,270 \u201cMulti-ancestry Genome-wide Association Meta-analysis of Buprenorphine Treatment Response,\u201d filed 29 October 2024. The rest of the authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"352"}}